SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 7/01/20 US Physical Therapy Inc/NV 8-K:8 7/01/20 1:44K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 33K
Nevada
|
|
|
76-0364866
|
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1300 West Sam Houston Parkway South,
|
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
|
Name of each exchange on which registered
|
|
Symbol(s)
|
|
Common Stock, $.01 par value
|
USPH
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
•
|
the multiple effects of the impact of public health crises and epidemics/pandemics, such as the novel strain of COVID-19 (coronavirus) which the
financial magnitude cannot be currently estimated;
|
•
|
changes in Medicare rules and guidelines and reimbursement or failure of our clinics to maintain their Medicare certification and/or enrollment
status;
|
•
|
governmental and other third party payor inspections, reviews, investigations and audits, which may result in sanctions or reputational harm and
increased costs;
|
•
|
compliance with federal and state laws and regulations relating to the privacy of individually identifiable patient information, and associated fines
and penalties for failure to comply;
|
•
|
changes in reimbursement rates or payment methods from third party payors including government agencies, and changes in the deductibles and co-pays
owed by patients;
|
•
|
competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses
and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
|
•
|
competitive environment in the industrial injury prevention business, which could result in the termination or non-renewal of contractual service
arrangements and other adverse financial consequences for that service line;
|
•
|
acquisitions, purchase of non-controlling interests (minority interests) and the successful integration of the operations of the acquired businesses;
|
•
|
maintaining our information technology systems with adequate safeguards to protect against cyber-attacks;
|
•
|
a security breach of our or our third party vendors’ information technology systems may subject us to potential legal action and reputational harm
and may result in a violation of the Health Insurance Portability and Accountability Act of 1996 of the Health Information Technology for Economic and Clinical Health Act;
|
|
||
|
|
|
U.S. PHYSICAL THERAPY, INC.
|
|||||
Dated: July 1, 2020
|
|
|
By:
|
|
|||
|
|
|
|||||
|
|
|
Chief Financial Officer
|
||||
|
|
|
(duly authorized officer and principal financial and accounting officer)
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 7/1/20 | |||
6/30/20 | ||||
5/21/20 | 10-Q, 8-K | |||
2/28/20 | 10-K, 4 | |||
12/31/19 | 10-K, 10-K/A | |||
List all Filings |